Almac Pharma Services, a member of the Almac Group, announced it is entering the final phase of a $79M million investment to expand its existing drug product manufacturing capabilities at its global headquarter site in Craigavon, Northern Ireland.
Responding to increased demand for product development and manufacturing services, the expansion will support the company’s existing global partnerships and reinforce its strong track record of providing superior drug development, manufacture and commercial packaging and distribution services.
The custom built GMP facility will come on-line in Q3 2024 and will extend to 100,000ft2/ 9,300m2 with bespoke, state-of-the-art production suites, lineside warehousing for ambient, refrigerated and frozen storage and associated support areas.
The new facility, which will primarily support solid oral dose products, will complement Almac’s existing capabilities in this area. It includes an extension to current scales of production for products involving potent and highly potent APIs. The high-specification production suites, which will be operated by Almac’s expert scientific and operational teams, have been designed with flexibility and a wide range of uses in mind. This offers opportunities for clients to install bespoke technology particular to their individual and emerging pipeline needs.
Operating out of four sites across Europe and the US with over 1,500 employees, Almac Pharma Services also has vast experience in providing a range of complementary packaging and delivery solutions with advanced systems and processes for managing the launch and ongoing supply of highly complex and Just-In-Time supply chain models. The fully integrated service offered by Almac Pharma Services delivers end-to-end solutions supporting clients as they move from early to late-stage development through to launch and commercial supply across global markets.
John McQuaid, President & Managing Director, Almac Pharma Services commented: “In the past five years we have experienced increased demand for our pharmaceutical development, commercial manufacturing and packaging solutions. Our strong track record and expertise in handling complex and challenging molecules across a range of batch scales enables us to offer clients a variety of solutions to meet the individual requirements of their products.